EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations

Luis P Del Carpio, Mar Varela, Mikel Portu, Sergi Villatoro, Elvira Purqueras, Montserrat Gomà, Daniel Lorenzo, Laura Lladò, Cristina Gutierrez, Emilio Ramos, Josep M Caminal, Josep M Piulats

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2025.115591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Luis P Del Carpio und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Institut Català d'Oncologia. L'Hospitalet del Llobregat, Barcelona, Spain; Cancer Immunotherapy (CIT) Group - iPROCURE, …. Hauptthemen laut MEDLINE: RNA Splicing Factors, Uveal Neoplasms, Melanoma, Mutation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Spanish Society of Medical Oncology, Spanish Association Against Cancer Scientific Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA Splicing FactorsUveal NeoplasmsMelanomaMutationPhosphoproteinsBiomarkers, TumorHumansFemaleMaleMiddle AgedUveal MelanomaAgedRetrospective StudiesAdultPrognosisDNA Copy Number VariationsAged, 80 and overProspective StudiesChromosomes, Human, Pair 3Chromosomes, Human, Pair 8GTP-Binding Protein alpha Subunits, Gq-G11

Stichwörter der Autor:innen

Metastatic uveal melanomaMonosomy 3PrognosisSF3B1Somatic copy number alterationsSurvival

Substanzen

RNA Splicing FactorsSF3B1 protein, humanPhosphoproteinsBiomarkers, TumorGNAQ protein, humanGTP-Binding Protein alpha Subunits, Gq-G11

Autor:innen und Institutionen

  • Medical Oncology Department, Institut Català d'Oncologia. L'Hospitalet del Llobregat, Barcelona, Spain; Cancer Immunotherapy (CIT) Group - iPROCURE, IDIBELL-OncoBell, L'Hospitalet del Llobregat, Barcelona, Spain. Electr…
  • Department of Pathology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Laboratori Core d'Anàlisi Molecular, Hospital Universitari de Bellvitge-Institut Català d'Oncologia, L'Hospitalet…
  • Medical Oncology Department, Institut Català d'Oncologia. L'Hospitalet del Llobregat, Barcelona, Spain.
  • Department of Pathology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Ophthalmology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Hepatic Surgery Department, Hospital de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.

Förderung

  • Spanish Society of Medical Oncology
  • Spanish Association Against Cancer Scientific Foundation

Zitieren

APA

Del Carpio, L. P., Varela, M., Portu, M., Villatoro, S., Purqueras, E., Gomà, M., Lorenzo, D., Lladò, L., Gutierrez, C., Ramos, E., Caminal, J. M., & Piulats, J. M. (2025). Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115591

Vancouver

Del Carpio LP, Varela M, Portu M, Villatoro S, Purqueras E, Gomà M, et al. Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115591

BibTeX
@article{DelCarpio2025,
  author = {Del Carpio, Luis P and Varela, Mar and Portu, Mikel and Villatoro, Sergi and Purqueras, Elvira and Gomà, Montserrat and Lorenzo, Daniel and Lladò, Laura and Gutierrez, Cristina and Ramos, Emilio and Caminal, Josep M and Piulats, Josep M},
  title = {Molecular determinants of survival in metastatic uveal melanoma: The impact of SF3B1 mutations},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2025.115591}
}
Kostenlos starten →